Cargando…
In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV
An outbreak of a cluster of viral pneumonia cases, subsequently identified as coronavirus disease 2019 (COVID-19), due to a novel SARS-CoV-2 necessitates an urgent need for a vaccine to prevent infection or an approved medication for a cure. In our in silico molecular docking study, a total of 173 c...
Autores principales: | Udofia, Inemesit A., Gbayo, Kofoworola O., Oloba-Whenu, Oluwakemi A., Ogunbayo, Taofeek B., Isanbor, Chukwuemeka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992627/ https://www.ncbi.nlm.nih.gov/pubmed/33786291 http://dx.doi.org/10.1007/s13721-021-00299-2 |
Ejemplares similares
-
A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the
RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Sarma, Himakshi, et al.
Publicado: (2022) -
Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds
por: Zhu, Jiajie, et al.
Publicado: (2022) -
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2020) -
Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
por: Kuang, Yi, et al.
Publicado: (2023) -
SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome
por: Tardivat, Yann, et al.
Publicado: (2023)